BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14705827)

  • 1. Pancreatitis and duodenitis from sarcoidosis: successful therapy with mycophenolate mofetil.
    O'Connor AS; Navab F; Germain MJ; Freeman JK; Mulhern JG; O'Shea MH; Lipkowitz GS; Madden RL; Braden GL
    Dig Dis Sci; 2003 Nov; 48(11):2191-5. PubMed ID: 14705827
    [No Abstract]   [Full Text] [Related]  

  • 2. Idiopathic granulomatous interstitial nephritis responsive to mycophenolate mofetil therapy.
    Leeaphorn N; Stokes MB; Ungprasert P; Lecates W
    Am J Kidney Dis; 2014 Apr; 63(4):696-9. PubMed ID: 24315767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of severe refractory atopic dermatitis with mycophenolate mofetil.
    Grundmann-Kollmann M; Korting HC; Behrens S; Leiter U; Krähn G; Kaufmann R; Peter RU; Kerscher M
    Br J Dermatol; 1999 Jul; 141(1):175-6. PubMed ID: 10417549
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil therapy for sarcoidosis-associated uveitis.
    Bhat P; Cervantes-Castañeda RA; Doctor PP; Anzaar F; Foster CS
    Ocul Immunol Inflamm; 2009; 17(3):185-90. PubMed ID: 19585361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of atopic dermatitis with mycophenolate mofetil.
    Hansen ER; Buus S; Deleuran M; Andersen KE
    Br J Dermatol; 2000 Dec; 143(6):1324-6. PubMed ID: 11122047
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of mycophenolate mofetil on cerulein-induced acute pancreatitis.
    Tasdogan B; Kucuk HF; Kurt N; Kaptanoglu L; Uzun H; Eser M
    Eur Surg Res; 2010; 45(3-4):146-50. PubMed ID: 20924190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful therapy of a patient with therapy recalcitrant generalized bullous scleroderma by extracorporeal photopheresis and mycophenolate mofetil.
    Schlaak M; Friedlein H; Kauer F; Renner R; Rogalski C; Simon JC
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):631-3. PubMed ID: 18410628
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycophenolate mofetil is effective for maintenance therapy of hypocomplementaemic urticarial vasculitis.
    Worm M; Sterry W; Kolde G
    Br J Dermatol; 2000 Dec; 143(6):1324. PubMed ID: 11122046
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of resistant hypertrophic and bullous lichen planus with mycophenolate mofetil.
    Nousari HC; Goyal S; Anhalt GJ
    Arch Dermatol; 1999 Nov; 135(11):1420-1. PubMed ID: 10566854
    [No Abstract]   [Full Text] [Related]  

  • 10. Mycophenolate mofetil for interstitial lung disease in scleroderma.
    Plastiras SC; Vlachoyiannopoulos PG; Tzelepis GE
    Rheumatology (Oxford); 2006 Dec; 45(12):1572. PubMed ID: 16998235
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful long-term treatment of severe atopic dermatitis with mycophenolate mofetil.
    Benez A; Fierlbeck G
    Br J Dermatol; 2001 Mar; 144(3):638-9. PubMed ID: 11260038
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycophenolate mofetil treatment for primary glomerular diseases.
    Levin ML
    Kidney Int; 2002 Oct; 62(4):1475. PubMed ID: 12234325
    [No Abstract]   [Full Text] [Related]  

  • 13. Mycophenolate mofetil (MMF) therapeutic approach in patients with chronic glomerulonephritis (GN).
    Bullo B; Zdrojewski Z; Rutkowski B
    Kidney Int; 2003 Sep; 64(3):1139. PubMed ID: 12911571
    [No Abstract]   [Full Text] [Related]  

  • 14. Mycophenolate mofetil for Crohn's disease.
    Atherton JC
    Gut; 2000 May; 46(5):740-1. PubMed ID: 10836856
    [No Abstract]   [Full Text] [Related]  

  • 15. Mycophenolate mofetil: implications for the treatment of glomerular disease.
    Badid C; Desmouliere A; Laville M
    Nephrol Dial Transplant; 2001 Sep; 16(9):1752-6. PubMed ID: 11522852
    [No Abstract]   [Full Text] [Related]  

  • 16. Mycophenolate mofetil treatment of a patient with hyperglobulinemic purpura.
    Waldman MA; Callen JP
    J Am Acad Dermatol; 2004 Oct; 51(4):667-9. PubMed ID: 15455483
    [No Abstract]   [Full Text] [Related]  

  • 17. Is mycophenolate mofetil a new alternative in the treatment of inflammatory bowel disease?
    Present DH
    Gut; 1999 May; 44(5):592-3. PubMed ID: 10205187
    [No Abstract]   [Full Text] [Related]  

  • 18. Early onset neutropenia after mycophenolate mofetil in systemic sclerosis.
    Cuomo G; Abignano G; Valentini G
    Rheumatol Int; 2009 Oct; 29(12):1529-30. PubMed ID: 19247660
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of mycophenolate mofetil on the pharmacokinetics of antiretroviral drugs and on intracellular nucleoside triphosphate pools.
    Sankatsing SU; Hoggard PG; Huitema AD; Sparidans RW; Kewn S; Crommentuyn KM; Lange JM; Beijnen JH; Back DJ; Prins JM
    Clin Pharmacokinet; 2004; 43(12):823-32. PubMed ID: 15355127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent.
    Megahed M; Schmiedeberg S; Becker J; Ruzicka T
    J Am Acad Dermatol; 2001 Aug; 45(2):256-9. PubMed ID: 11464188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.